Toxic airborne particles can travel from lungs and nose to the brain, and exposure is linked to memory loss
Rigorous new studies should be able to settle the matter
Being female is a risk factor for Alzheimer’s. Why?
Amyloid, the leading target for dementia therapy, faces skepticism after drug failures
Here are some “highlights” from the past 13.5 years of this podcast.
Fresh approaches and hopeful clues in the search for novel therapies
Some nominally high-risk individuals may have a lower chance of developing dementia than once thought
A new era for Alzheimer’s and journalism in the time of coronavirus
It is time for a fresh approach to the illness
Alzheimer’s took my wife’s memory and her life and tortured our family. There was nothing we—or medicine—could do to stop it
Most autistic individuals want to and can make friends, though their relationships often have a distinctive quality
The protein, once seen as a secondary player, has taken a leading role in combating neurodegenerative illnesses
Such children’s neural circuits do not transition properly from an active state to a resting one
Particular antioxidants in fruits and vegetables may lower chances of getting the disease
It may open the door to new treatments and explain why previous ones failed
A complex natural signaling system could help address impulse-control disorders
Promoting “healthspan” involves exercise and games
The disease may begin in the womb and require treatment early in life
Will the benefits of aducanumab be enough to justify FDA approval, given its small benefit and high price?
After a string of drug failures, researchers are looking beyond amyloid as a target